This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log in
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Aug;97(32):e11616.
doi: 10.1097/MD.0000000000011616.

Borderline tuberculoid leprosy mimicking sarcoidosis: A case report

Affiliations
Case Reports

Borderline tuberculoid leprosy mimicking sarcoidosis: A case report

Jian Liu et al. Medicine (Baltimore). 2018 Aug.

Abstract

Introduction: Leprosy is a chronic infectious granulomas disease caused by Mycobacterium leprae that can manifest as a wide variety of immunological and clinical features.

Case summary: Here, we describe the case of a woman with clinical characteristics of borderline tuberculoid (BT) leprosy that manifested as 3 asymmetric skin lesions involving her hip and lower limbs. This unusual presentation was initially misdiagnosed as sarcoidosis because noncaseating granulomas are a histopathological feature of both diseases. Differentiation and the diagnosis of BT leprosy was achieved using real-time polymerase chain reaction (PCR) to amplify an M leprae specific DNA sequence and to detect serum antibodies specific to M leprae antigens. Accordingly, a 6-month course of multidrug therapy led to a marked improvement in the skin lesions.

Conclusion: The use of auxiliary tests including real-time PCR to amplify an M leprae-specific DNA sequence, enzyme-linked immunosorbent assay, and dipstick detection of serum antibodies specific to M leprae antigens are good methods to obtain a correct diagnosis of BT leprosy.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest.

Figures

Figure 1
Figure 1
Macroscopic presentation of the plaques. (A) Palm-sized plaques are shown on the right hip. These plaques lacked a clear edge, and the fringes were raised higher than the skin. Normal skin is occasionally observed among the patches. (B) On the right leg, palm-sized plaques are present with varying shades of color, deep and shallow edges, and satellite foci. (C) On the inside of the right foot, the plaque has dark coloring, undefined edges, and satellite foci.
Figure 2
Figure 2
Microscopic observations of the skin biopsies. (A) Under ×ばつ magnification, thinning of the skin is not clearly seen, infiltration is not obvious, and shallow blood vessels are visible around the granulomatous adnexal tissue in the mid-dermis. (b) Under ×ばつ magnification, granulomatous changes are visible, with epithelioid cells and lymphocyte infiltration. (c) Under ×ばつ magnification, sections show a negative result with acid-fast staining.
Figure 3
Figure 3
Recovery of the skin lesions following multidrug therapy (MDT). After a 6-month course of MDT for PB leprosy, the lesions show improvement to a more normal profile. PB = paucibacillary.
Figure 4
Figure 4
Samples from the case generate (A) a positive band in a rapid lateral flow test based on the detection of antibodies against the NDO-leprosy IDRI diagnostic conjugate antigen and (B) yield a M leprae-specific fragment amplified by real-time polymerase chain reaction.

References

    1. Scollard DM, Adams LB, Gillis TP, et al. The continuing challenges of leprosy. Clin Microbiol Rev 2006;19:338–81. - PMC - PubMed
    1. Paula Vaz Cardoso L, Dias RF, Freitas AA, et al. Development of a quantitative rapid diagnostic test for multibacillary leprosy using smart phone technology. BMC Infect Dis 2013;13:497. - PMC - PubMed
    1. Pardillo FE, Fajardo TT, Abalos RM, et al. Methods for the classification of leprosy for treatment purposes. Clin Infect Dis 2007;44:1096–9. - PubMed
    1. Nicholls PG, Croft RP, Richardus JH, et al. Delay in presentation, an indicator for nerve function status at registration and for treatment outcome–the experience of the Bangladesh Acute Nerve Damage Study cohort. Lepr Rev 2003;74:349–56. - PubMed
    1. Nicholls PG, Ross L, Smith WC. Promoting early detection in leprosy–a literature review to identify proven and potential interventions addressing patient-related delay. Lepr Rev 2006;77:298–310. - PubMed

Publication types

Cite

AltStyle によって変換されたページ (->オリジナル) /